Xenon Pharmaceuticals Inc (XENE)

Oct 12, 2025

Will Xenon Pharmaceuticals Inc. stock attract more institutional investorsWeekly Trade Recap & Entry Point Confirmation Alerts - newser.com

Oct 12, 2025

Oct 12, 2025

Xenon Pharmaceuticals (XENE): Exploring Valuation After Recent Share Price Momentum - Yahoo

Oct 12, 2025

Oct 11, 2025

Leerink Partners Remains a Buy on Xenon (XENE) - The Globe and Mail

Oct 11, 2025

Oct 10, 2025

Research Analysts Issue Forecasts for XENE FY2025 Earnings - MarketBeat

Oct 10, 2025

Oct 10, 2025

What is Bloom Burton’s Estimate for XENE FY2025 Earnings? - Defense World

Oct 10, 2025

Oct 09, 2025

Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees - MSN

Oct 09, 2025

Oct 09, 2025

Will Xenon Pharmaceuticals Inc. stock attract ESG investorsDay Trade & Free Weekly Watchlist of Top Performers - newser.com

Oct 09, 2025

Oct 09, 2025

Is Xenon Pharmaceuticals Inc. stock attractive for income investors2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com

Oct 09, 2025

Oct 08, 2025

What analysts say about Xenon Pharmaceuticals Inc stockInsider Selling Patterns & Budget Friendly Trading Strategies - earlytimes.in

Oct 08, 2025

Oct 08, 2025

Brokers Offer Predictions for XENE FY2026 Earnings - MarketBeat

Oct 08, 2025

Oct 08, 2025

Bloom Burton Upgrades Xenon Pharmaceuticals (NASDAQ:XENE) to "Strong-Buy" - MarketBeat

Oct 08, 2025

Oct 08, 2025

Xenon Pharmaceuticals’ (XENE) Outperform Rating Reaffirmed at William Blair - Defense World

Oct 08, 2025

Oct 08, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Given “Buy” Rating at Chardan Capital - Defense World

Oct 08, 2025

Oct 07, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 07, 2025

Oct 07, 2025

77,750 Options: Xenon Pharmaceuticals Grants Equity to Seven New Hires at $39.20, Oct 2, 2025 - Stock Titan

Oct 07, 2025

Oct 07, 2025

Xenon Pharmaceuticals' (XENE) Outperform Rating Reiterated at William Blair - MarketBeat

Oct 07, 2025

Oct 07, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Receives "Buy" Rating from Chardan Capital - MarketBeat

Oct 07, 2025

Oct 07, 2025

XENE: Chardan Capital Maintains Buy Rating with $55 Price Target | XENE Stock News - GuruFocus

Oct 07, 2025

Oct 07, 2025

Chardan Capital Maintains Xenon Pharmaceuticals (XENE) Buy Recommendation - Nasdaq

Oct 07, 2025

Oct 06, 2025

Transcript : Xenon Pharmaceuticals Inc.Special Call - MarketScreener

Oct 06, 2025

Oct 06, 2025

Will Xenon Pharmaceuticals Inc. stock recover after recent dropJobs Report & Verified Swing Trading Watchlist - newser.com

Oct 06, 2025

Oct 05, 2025

Is it time to cut losses on Xenon Pharmaceuticals Inc.Market Growth Summary & Safe Capital Investment Plans - newser.com

Oct 05, 2025

Oct 04, 2025

Xenon Pharmaceuticals Inc. $XENE Shares Purchased by J. Safra Sarasin Holding AG - MarketBeat

Oct 04, 2025

Oct 03, 2025

Xenon Pharmaceuticals announces executive changes - MSN

Oct 03, 2025

Oct 03, 2025

HighMark Wealth Management LLC Has $817,000 Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Oct 03, 2025

Oct 03, 2025

Xenon Pharmaceuticals Inc. stock chart pattern explainedWeekly Volume Report & Low Risk Entry Point Tips - newser.com

Oct 03, 2025

Oct 03, 2025

Will Xenon Pharmaceuticals Inc. stock maintain growth storyGap Down & Free AI Powered Buy and Sell Recommendations - newser.com

Oct 03, 2025

Oct 02, 2025

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - MarketBeat

Oct 02, 2025

Oct 01, 2025

Insider Selling: Xenon Pharmaceuticals (NASDAQ:XENE) CEO Sells 25,000 Shares of Stock - MarketBeat

Oct 01, 2025

Oct 01, 2025

Xenon Pharmaceuticals Hits Day High with Strong 9.94% Intraday Surge - Markets Mojo

Oct 01, 2025

Oct 01, 2025

Published on: 2025-10-01 07:26:08 - newser.com

Oct 01, 2025

Oct 01, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat

Oct 01, 2025